← Open Payments lookup

CATHERINE SMITH: Open Payments

NPI 1023608072 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,221 in 59 payments from 12 companies in 2025. Trend: 2023 $714 · 2024 $611 · 2025 $1,221

Food & beverage: $1,221
CompanyPaymentsAmount
Collegium Pharmaceutical, Inc.14$263
Corium, LLC11$253
Neos Therapeutics, LP7$117
Supernus Pharmaceuticals, Inc.5$114
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$106
Tempus AI, Inc4$89
Alkermes, Inc.4$79
Otsuka America Pharmaceutical, Inc.3$69
Tris Pharma Inc3$63
Takeda Pharmaceuticals U.S.A., Inc.1$32

Products named: Jornay PM, Azstarys, Qelbree, CAPLYTA, TEMPUS PIXEL, Adzenys XR-ODT, Onyda XR, ARISTADA.

Industry payments across TX — which companies pay providers there.